Athlome Project Consortium: a concerted effort to discover genomic and other “omic” markers of athletic performance
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Despite numerous attempts to discover genetic variants associated with elite athletic performance, injury predisposition, and elite/world-class athletic status, there has been limited progress to date. Past reliance on candidate gene studies predominantly focusing on genotyping a limited number of single nucleotide polymorphisms or the insertion/deletion variants in small, often heterogeneous cohorts (i.e., made up of athletes of quite different sport specialties) have not generated the kind of results that could offer solid opportunities to bridge the gap between basic research in exercise sciences and deliverables in biomedicine. A retrospective view of genetic association studies with complex disease traits indicates that transition to hypothesis-free genome-wide approaches will be more fruitful. In studies of complex disease, it is well recognized that the magnitude of genetic association is often smaller than initially anticipated, and, as such, large sample sizes are required to identify the gene effects robustly. A symposium was held in Athens and on the Greek island of Santorini from 14–17 May 2015 to review the main findings in exercise genetics and genomics and to explore promising trends and possibilities. The symposium also offered a forum for the development of a position stand (the Santorini Declaration). Among the participants, many were involved in ongoing collaborative studies (e.g., ELITE, GAMES, Gene SMART, GENESIS, and POWERGENE). A consensus emerged among participants that it would be advantageous to bring together all current studies and those recently launched into one new large collaborative initiative, which was subsequently named the Athlome Project Consortium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Should donors be allowed to give broad consent to future biobank research?
Hansson, M. G., Dillner, J., Bartram, C. R., Carlson, J. A., & Helgesson, G. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70618-0 · Cited by 382 · cited 1×
“” The nomenclature here is important since this notion is variously described as “broad consent,” “blanket consent,” “future consent,” “hypothetical consent,” “passive/tacit/silent consent,” or “waived consent” (4, 5).”
Cited by
Landen, S., Hiam, D., Voisin, S., Jacques, M., Lamon, S., & Eynon, N. (2023) · The Journal of Physiology · doi:10.1113/jp279499 · Cited by 137
“Larger scale and consortium-based studies (Pitsiladis et al. 2016) are therefore warranted to elucidate sex differences in various aspects of exercise training (Figs.”
BackgroundSelf-citationWhy nature prevails over nurture in the making of the elite athlete.
Georgiades, E., Klissouras, V., Baulch, J., Wang, G., & Pitsiladis, Y. (2017) · BMC Genomics · doi:10.1186/s12864-017-4190-8 · Cited by 50
“Notable highlights in this regard from the Athlome Consortium is the first published GWAS of athletic performance [52] and the declaration of the sequencing of 1000 of the world’s greatest athletes in the 1000 Athlomes project [53].”
BackgroundSelf-citationHill, J. R., Eekhoff, J. D., Brophy, R. H., & Lake, S. P. (2020) · Journal of Orthopaedic Research · doi:10.1002/jor.24695 · Cited by 24
Preface: genomics and biology of exercise is undergoing a paradigm shift.
Eynon, N., Voisin, S., Lucia, A., Wang, G., & Pitsiladis, Y. (2017) · BMC Genomics · doi:10.1186/s12864-017-4184-6 · Cited by 13
Self-citation
Metadata
- Authors
- Pitsiladis, Y. P., Tanaka, M., Eynon, N., Bouchard, C., North, K. N., Williams, A. G., Collins, M., Moran, C. N., Britton, S. L., Fuku, N., Ashley, E. A., Klissouras, V., Lucia, A., Ahmetov, I. I., de Geus, E., Alsayrafi, M., & Athlome Project Consortium
- Venue
- Physiological Genomics
- Publisher
- American Physiological Society
- Published
- 2016-03
- Volume
- 48
- Issue
- 3
- Pages
- 183-190
- ISSN
- 1094-8341 (ISSN-L)
- 1531-2267
- OpenAlex
- W2235242562
- Cited by
- 124
- References
- 1
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.